DDNews asks Dr. Rohit Khanna, vice president of worldwide marketing for the Waters Division
of Waters Corp., to share his views on the advances in mass spectrometry and how they are impacting healthcare delivery
Reportedly the largest human genetics meeting and exposition in the world, the ASHG
gathering from Oct. 18 to 22 will cover ethics in genomics, advances in sequencing and much else, attracting more than 6,500 scientific attendees and
featuring well over 200 exhibiting companies
There is no doubt that Ebola is a monumental
problem, and it's a notable part of our September issue coverage. But there's also been a lot of excessive fear and hype as well, which has perhaps made
the disease look like something out of an apocalyptic novel or film. On the bright side, the increased attention seems to have mobilized many pharmas,
biotechs, government agencies and others to increase the pace of Ebola diagnostics and therapies, which could be welcome relief to the people most at risk of
the disease.
Off-
label prescribing of pharmaceutical products by physicians has a long history and even some notable successes, but the practice also poses many challenges
and risks.
The U.S. Food and Drug Administration was been busy in spring 2014, releasing two new
guidances (in May and August) relating to its evolving standards for satisfying the biosimilarity requirements of the Biologics Price Competition and
Innovation Act.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.